3rd Quarter

3rd Quarter

ADVANCES IN RESEARCH & DEVELOPMENT STUDIES

Further studies are underway to deepen our understanding of the therapy’s administration methods. The results obtained confirm the effectiveness of REMaST in promoting motor recovery and tissue regeneration in animal models of spinal cord injury, even when using the intrathecal route. This intrathecal approach has proven to be less invasive compared to the methods used so far, representing a significant step forward in the research toward safer and more feasible treatments

SCIENTIFIC PUBLICATION: A SIGNIFICANT STEP FORWARD

Hemera’s scientific work on the preclinical results of REMaST is currently under review by a prestigious high-impact scientific journal. In the meantime, the publication is available as a preprint on the public portal bioRxiv at the following link: [View Publication].

HEMERA WINS THE ITALIAN MASTER STARTUP AWARD

Hemera has been awarded the IMSA-Italian Master Startup Award 2024, a prestigious recognition from PNI Cube, the Association of Italian Incubators and Italian academic business plan competitions, as well as I3P, the Incubator of the Polytechnic University of Turin. The award was conferred by a specialized jury composed of representatives from investment funds, entrepreneurs, and business angels, in front of an audience of entrepreneurs and representatives from national and European institutions.